From: PReS-FINAL-2119: United Kingdom survey of current management of juvenile localised scleroderma
Treatment Used | Reported use by prs (% of respondents) | Reported use by dms (% of respondents) |
---|---|---|
Topical treatments Systemic steroids Ultraviolet light Methotrexate Ciclosporin Hydroxychloroquine Anti-TNF Mycophenolate mofetil Cyclophosphamide | 10 90 0 100 30 40 60 90 30 | 100 79 68 96 32 11 4 18 0 |